Resources with keywords: bivalent



CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine (NEW 6/12, Website, Regulatory)
CDC
COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 (Website, Regulatory)
CDC/MMWR
10 February 2023

Johnson AG, Linde L, Ali AR, et al.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022 (Website, Publication, Regulatory)
CDC/MMWR
30 December 2022

Surie D, DeCuir J, Zhu Y, et al.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 (Website, Publication, Regulatory)
CDC/MMWR
30 December 2022

Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al.

Stay Up to Date with COVID-19 Vaccines Including Boosters (Website, Regulatory)
CDC
Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (Website, Regulatory)
FDA
12 October 2022
Go to Top